36441-41-5|Antibiotic SF 767 A|Antibiotic SF 767 A|-范德生物科技公司

Antibiotic SF 767 A

NMR下载 COA and HPLC MSDS下载
names：
Antibiotic SF 767 A
CAS号：
36441-41-5
MDL Number：
MF(分子式)： C29H55N5O18 MW(分子量)： 761.77
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	(2R,3S,4S,5S,6R)-2-(((2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-(((2R,3R,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-diamino-2-(((2S,3R,5S,6R)-3-amino-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)oxy)-4-hydroxytetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
英文别名	Lividomycin; Antibiotic SF 767 A; SF 767 A; SF-767 A; SF767 A; Antibiotic 503-2; Lividomicina;
CAS号	36441-41-5
SMILES	N[C@H]1[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@@H]([C@H]2O)O[C@@H]3[C@H](N)[C@@H](O)[C@H](O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)[C@H](CN)O3)[C@@H]([C@@H](N)C1)O[C@H]5O[C@H](CO)[C@@H](O)C[C@H]5N
Inchi	InChI=1S/C29H55N5O18/c30-3-11-23(51-28-20(43)19(42)17(40)13(5-36)47-28)18(41)15(34)27(45-11)50-24-14(6-37)48-29(21(24)44)52-25-16(39)7(31)1-8(32)22(25)49-26-9(33)2-10(38)12(4-35)46-26/h7-29,35-44H,1-6,30-34H2/t7-,8+,9-,10+,11+,12-,13-,14-,15-,16+,17-,18-,19+,20+,21-,22-,23-,24+,25-,26-,27-,28-,29+/m1/s1
InchiKey	DBLVDAUGBTYDFR-RRCSYQSCSA-N
分子式 Formula	C29H55N5O18
分子量 Molecular Weight	761.77
闪点 FP
熔点 Melting point
沸点 Boiling point
Polarizability极化度
密度 Density
蒸汽压 Vapor Pressure
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Antibiotic SF 767 A(CAS:36441-41-5):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Antibiotic SF 767 A is an antibiotic.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Clausnitzer D, Piepersberg W, Wehmeier UF. The oxidoreductases LivQ and NeoQ are responsible for the different 6'-modifications in the aminoglycosides lividomycin and neomycin. J Appl Microbiol. 2011 Sep;111(3):642-5[1]doi: 10.1111/j.1365-2672.2011.05082.x. Epub 2011 Jul 12. PubMed PMID: 21689223.

[2]Kobayashi F, Yamaguchi M, Mitsuhashi S. Activity of lividomycin against Pseudomonas aeruginosa: its inactivation by phosphorylation induced by resistant strains. Antimicrob Agents Chemother. 1972 Jan;1(1):17-21. PubMed PMID: 4207755; PubMed Central PMCID: PMC444159.

[3] Mori T, Kyotani Y, Watanabe I, Oda T. Chemical conversion of lividomycin A into lividomycin B. J Antibiot (Tokyo). 1972 Feb;25(2):149-50. PubMed PMID: 5034809.

[4] Yamaguchi M, Koshi T, Kobayashi F, Mitsuhashi S. Phosphorylation of lividomycin by Escherichia coli carrying an R factor. Antimicrob Agents Chemother. 1972 Sep;2(3):142-6. PubMed PMID: 4597704; PubMed Central PMCID: PMC444281.

[5] Kondo H, Miwa T, Suhachiro M, Yokouchi S, Ando Y. [Clinical experiences of lividomycin on respiratory tract infections (author's transl)]. Jpn J Antibiot. 1975 Apr;28(2):149-54. Japanese. PubMed PMID: 1041282.

6: Yamamoto H, Kondo S, Maeda K, Umezawa H. Synthesis of lividomycin A 5''-phosphate, an enzymatically inactivated lividomycin A. J Antibiot (Tokyo). 1972 Aug;25(8):485-6. PubMed PMID: 4648492.7: Takahashi R, Kato S. [Lividomycin therapy in intestinal infections with special reference to the combined use of lividomycin and AB-PC]. Kansenshogaku Zasshi. 1973 Aug;47(8):283-8. Japanese. PubMed PMID: 4202860.8: Kuntzmann F, Weiss JM, Berthel M, Colonna JC, Conraux C, Reinhardt W, Brogard JM, Federspil P. [Ototoxicity of aminoglucosides. A case of deafness after lividomycin]. Nouv Presse Med. 1979 Apr 28;8(19):1604-5. French. PubMed PMID: 258790.9: Yamaguchi M, Eda J, Kobayashi F, Mitsuhashi S. Mode of action of lividomycin on protein synthesis in Escherichia coli. Antimicrob Agents Chemother. 1973 Sep;4(3):380-2. PubMed PMID: 4586150; PubMed Central PMCID: PMC444562.10: Tsukamura M. A preliminary trial of lividomycin in patients with pulmonary tuberculosis. Tubercle. 1972 Mar;53(1):43-6. PubMed PMID: 5038199.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开